Bandingkan Harga & Kinerja Lippo Karawaci Tbk. (LPKR) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Lippo Karawaci Tbk. dan Organon Pharma Indonesia Tbk.: Lippo Karawaci Tbk. diperdagangkan di Rp61 (kapitalisasi pasar 4,32 T, volume 24 jam 78,75 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Lippo Karawaci Tbk. jauh lebih besar — sekitar 41,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| LPKR | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 4,32 T | 104,4 M |
Volume | 78,75 jt | — |
Lot | 787,51 rb | — |
Perputaran | 4,81 M | — |
Harga Rata-rata | 61,05 | — |
Nilai Transaksi | 4,81 M | — |
Harga Ekuilibrium Indikatif | 61 | — |
Volume Ekuilibrium Indikatif | 28,62 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Lippo Karawaci Tbk.
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Selengkapnya di halaman LPKR →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
